Form 4 for WST West Pharmaceutical Services
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001127602-25-006123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2025-02-18 | WST | Reiss-Clark Cindy | Chief Commercial Off | F - Tax | $211.00 | -83.18 | 5,047 | -2% | -$17.6K |
| D | 2025-02-20 | 2025-02-18 | WST | Reiss-Clark Cindy | Chief Commercial Off | M - OptEx | $211.00 | +246.16 | 5,131 | +5% | +$51.9K |
| DM | 2025-02-20 | 2025-02-18 | WST | Reiss-Clark Cindy | Chief Commercial Off | A - Grant | $0.00 | +1,665 | 1,162 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | F | D | 83.18 | $211.00 | 5,047.33 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | M | A | 246.16 | $211.00 | 5,130.51 | D | — | — | |
| 3 | Derivative | Rst. Stock Unit | 2025-02-18 | A | A | 503 | $0.00 | 503 | D | $0.00 · — to — | 503 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-18 | A | A | 1,162 | $0.00 | 1,162 | D | $211.00 · 2026-02-18 to 2035-02-18 | 1,162 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |